述评(Commentary)

肝细胞癌肝切除术的争议

Published at: 2017年第26卷第1期

钟鉴宏 1 , 游雪梅 1 , 黎乐群 1
1 广西医科大学附属肿瘤医院 肝胆外科,广西 南宁 530021
通讯作者 乐群 黎 Email: xitongpingjia@163.com
DOI: 10.3978/j.issn.1005-6947.10.3978/j.issn.1005-6947.2017.01.001
基金:

摘要

肝切除术是早期肝细胞癌(HCC)的标准治疗方案,但由于围手术期并发症发生率、病死率、远期无瘤生存率和总生存率等问题,肝切除术应用于中晚期HCC以及肝硬化合并门静脉高压症的患者尚存在争议,笔者围绕这些问题展开讨论。


Controversies in hepatic resection for hepatocellular carcinoma

Abstract

Hepatic resection is the standard treatment for early-stage hepatocellular carcinoma (HCC). However, its application in HCC patients at middle- and advanced-stage or with portal hypertension is controversial because of the high incidence of perioperative complications and mortality rates, and low long-term disease-free and overall survival rates. Here, the authors discuss the issues of these concerns.


comments powered by Disqus

全文

引用

引用本文: 鉴宏 钟, 雪梅 游, 乐群 黎. 肝细胞癌肝切除术的争议[J]. 中国普通外科杂志, 2017, 26(1): 1-5.
Cite this article as: ZHONG Jianhong, YOU Xuemei, LI Lequn . Controversies in hepatic resection for hepatocellular carcinoma [J]. Chin J Gen Surg, 2017, 26(1): 1-5.